Unusual metastasis of esophageal cancer by Vidović Vladimir et al.
Vojnosanit Pregl 2014; 71(10): 975–977. VOJNOSANITETSKI PREGLED Strana 975
Correspondence to: Vladimir Vidoviý, Oncology Institute of Vojvodina, Put dr Goldmana 4, 21 204 Sremska Kamenica, Serbia. Phone:
+381 69 130 3000, E-mail: vladimir_vidovic@hotmail.com
CASE REPORT UDC: 616.329-006-033.2-07/-08
DOI: 10.2298/VSP1410975V
Unusual metastasis of esophageal cancer
Neobiþna metastaza karcinoma jednjaka
Vladimir Vidoviü*, Ivan Nikoliü*, Jelena Vukojeviü*, Golub Samardžija
†,
Biljana Kukiü*, Bogdan Bogdanoviü*, Nemanja Petroviü*
*Oncology Institute of Vojvodina, Sremska Kamenica, Serbia; 
†Institute for
Cardiovascular Diseases of Vojvodina, Sremska Kamenica, Serbia
Abstract
Introduction. Carcinoma of the esophagus is in the eighth
place by the frequency of malignant diseases and the sixth
cause of death from cancer worldwide. It usually metastasizes
to regional lymph nodes, liver, lungs, central nervous system,
and bones, but metastases can appear to unusual locations
such as facial skin and lips. Case report. We presented a 56-
year-old man who reported to his physician because of upper
lip swelling. A physical checkup of the patients also showed a
lesion on the skin of the left temporal region and both lesions
were biopsied. Based on the results of histopathological and
immunohistochemical analyses of the samples a diagnosis of
metastatic adenocarcinoma to the skin was established. Addi-
tional diagnostic procedures, including esophagogastroduo-
denoscopy, detected the infiltration into the distal part of
esophagus, which was histopathologically confirmed as ade-
nocarcinoma of esophagus. The results of positron emission
tomography/computed tomography (PET/CT) examination
showed the invasion of the disease. Because of the disease
expansion, a multidisciplinary oncology team suggested
chemo- and radiotherapy treatment. The patient has received
4 cycles of platinum-based chemotherapy so far. Conclu-
sion. The physicians should always consider unusual skin le-
sions as the first sign of cancer spreading.
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Apstrakt
Uvod. Karcinom jednjaka je osmi karcinom po uÿestalo-
sti i šesti uzrok smrti od karcinoma u svetu. Najÿešýe
metastazira u regionalne limfne ÿvorove, jetru, pluýa,
centralni nervni sistem, kosti, ali se sreýu metastaze i na
neuobiÿajenim mestima kao što su koža lica i usne. Pri-
kaz bolesnika. Prikazali smo bolesnika starog 56 godina
koji se javio lekaru zbog otekline u predelu gornje usne.
Pregledom je viĀena i promena u predelu kože slepooÿ-
nog predela glave sa leve strane te su u istom aktu ekstir-
pirane obe promene. Patohistološkim pregledom, uklju-
ÿujuýi imunohistohemijsku analizu, postavljena je dijag-
noza metastatskog adenokarcinoma u koži. Dopunskom
dijagnostikom, ukljuÿujuýi ezofagogastroduodenoskopiju
viĀena je infiltracija distalnog dela jednjaka, ÿiji je patohis-
tološki nalaz potvrdio dijagnozu adenokarcinoma jednjaka.
Pozitronska emisiona tomografija-kompjuterizovana tomo-
grafija (PET/CT) je ukazala na proširenost bolesti. S obzi-
rom na proširenost bolesti multidisciplinarni onkološki
tim je predložio hemioterapiju i radioterapiju. Bolesnik je
do sada primio ÿetiri serije hemioterapije po protokolu sa
platinom. Zakljuÿak. Lekari moraju imati na umu da ne-
uobiÿajene promene na koži mogu biti prvi znak prošire-
nosti karcinoma.
Kljuÿne reÿi:
jednjak, neoplazme; neoplazme, metastaze; usna;
dijagnoza; adenokarcinom; histološke tehnike;
imunohistohemija.
Introduction
Carcinoma of the esophagus is sixth cause of death from
cancer worldwide (fifth cause from cancer among men and
eighth among women). China, countries of Central Asia, and
certain parts of America are the regions with the highest inci-
dence. In Europe, carcinoma of the esophagus is a rare malig-
nant disease 
1. In Serbia about 460 newly diagnosed patients
are registered annually 
2. The highest incidence is in the region
of Vojvodina and it ranges 7 new cases per 100,000 yearly.
Mostly it affects older population in the sixth decade of life.
Adenocarcinoma of the esophagus most frequently metasta-
sizes to regional lymph nodes, liver, lungs, central nervous
system, bones and rarely to facial skin and scalp.
Case report
A 56-year-male patient visited the physician because of
the skin lesion on his upper lip and skin of the left temporal
region. Both lesions were biopsied and the samples wereStrana 976 VOJNOSANITETSKI PREGLED Volumen 71, Broj 10
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histopathologically analyzed. Based on routine hematoxylin
and eosin staining (Figure 1) the diagnosis of metastatic ade-
nocarcinoma was established. Because of the immunoprofile
of tumor cells [cytokeratin (CK) 7 positive (Figure 2),
epithelial membrane antigen (EMA) positive (Figure 3 and
4), carcinoembryonic antigen epithelial membrane antigen
(CEA) positive, CK20, and thyroid transcription factor-1
(TTF-1) negative] additional immunohistochemical analysis
of tumor tissue was done. The results presented as adenocar-
cinoma metastasis to skin.
Fig. 1 – Mucosa and submucosa of the esophagus infiltrated by tumor tissue (hematoxylin and eosin staining, × 10).
Fig. 2 – Tumor tissue infiltration into the skin of the upper lip (Cytokeratin7+, × 4).
Fig. 3 –Tumor tissue infiltration into the skin of the upper lip (Epithelial membrane antigen +, × 4).
Fig. 4 – Tumor tissue infiltration into the skin of the left temporal region (Epithelial membrane antigen +, × 4).Volumen 71, Broj 10 VOJNOSANITETSKI PREGLED Strana 977
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Differential diagnosis procedure referred to primary ade-
nocarcinoma of gastrointestinal tract. The patient has been suf-
fering from rheumatoid arthritis for 10 years. He consumes al-
cohol moderately and quitted smoking 27 years ago. He smoked
about 15 years on the average 30 cigarettes per day. As he com-
plained of swallowing difficulties esophagogastroduodenoscopy
was performed. The examination results showed an infiltrative
stenosis of esophagus at 38 cm of its length, which was impass-
able for the tip of the instrument.  The lesion was biopsied and
the sample was histopathologically analyzed. The result showed
a well-differentiated adenocarcinoma. The findings of computed
tomography (CT) examination of the chest and abdomen indi-
cated the presence of single lymph nodes in mesentery up to 6
mm in size and one small lymph node conglomerate of 14 × 8
mm. Bilateral diffuse nodular lesions found in lung parenchyma
were most probably secondary deposits. In addition, CT findings
evidenced lesion infiltration into the distal part of the esophagus
and cardia. The patient was referred to positron emission tomog-
raphy (PET)-CT examination by the surgeon to evaluate the ex-
pansion of the primary disease. The findings of the examination
showed metabolic activity of lymph nodes in the axilla, bron-
chopulmonary segment right, preaortic space, and bilaterally in
mesentery. The active focuses were also detected in the liver
right lobe, skeleton (left arm, right shoulder blade, rib 9 right,
cervical vertebra 7, lumbar vertebrae 1, 2, and 4, pelvic bones
bilaterally, and proximal ends of both femur. Thyroid gland was
polynodally changed and enlarged. A multidisciplinary oncol-
ogy team indicated the treatment with chemotherapy (adriamy-
cin 40 mg/m
2 at the day 1; 5-fluouracil 300 mg/m
2 at the day 1–
5; cisplatin 20 mg/m
2 at the day 1–5, every four weeks) and ra-
diotherapy. So far, the patient was administered 4 cycles of
chemotherapy, not associated with any significant side effects.
The patient reported smaller swallowing problems. Radiother-
apy has not been initiated yet.
Discussion
The incidence of esophageal adenocarcinoma is signifi-
cantly increasing
 3, 4. Most patients present at the advanced
stage where therapeutic measures with a curative intent are
not feasible 
5. Carcinoma of the esophagus characterized
with biologically aggressive course, local infiltration, in-
volvement of adjacent lymph nodes, and distant metastases
by means of hematogenous routes
 6. Most frequently it me-
tastasizes to lymph nodes (45%), liver (35%), lungs (20%),
skeleton (10%), peritoneum (2%), and brain (1.5%)
 7. In total
of 4,000 cases of metastatic esophageal carcinoma skin me-
tastases were found in about 10% of patients
 7. Squamous
cell carcinoma and adenocarcinoma of the esophagus me-
tastasize to the skin with and equal frequency in less than 1%
of cases. Similar to our case, Nisi et al. 
8 report a case of eso-
phageal carcinoma with upper lip metastases. The patient
was confirmed to be affected with adenocarcinoma of the
gastroesophageal junction with secondary deposits. Iwanski
et al. 
9 describe a patient with disseminated and extensive
skin lesions. Histopathological analyses of these lesions
show the presence of esophageal carcinoma. Maheshwari et
al. 
10 report a case of a female patient with skin lesions and
difficulties in swallowing. Adequate diagnostic procedures
and histopathological analysis of the lesions confirm skin
metastases.  Herbella et al. 
7 describe a case of a patient with
dysphagia and painless but rapidly advancing ulcerations on
nose and neck, which all were histopathologically verified as
metastases from squamous cell carcinoma of the esophagus.
There is also a report on a patient presented with skin lesions
two years after the operation of adenocarcinoma of the gas-
troesophageal junction; the lesion was histoptahologically
verified as adenocarcinoma 
7. Metastasizing of esophageal
adenocarcinoma to the upper lip is rare and with poor prog-
nosis because of the high probability of secondary localiza-
tion of the disease 
8. In total a 4-year survival of patients af-
fected with carcinoma of the esophagus, regardless the stage
of the disease, is lower than 10%, and 21% after the surgical
treatment
 11.
Conclusion
Physicians should always consider unusual lesion of the
skin, which may be the first sign of disease expansion.
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